Freenome

Freenome combines AI-powered multiomics with simple blood draws to detect cancer earlier; its SimpleScreen CRC test earned FDA approval in 2026.

Backed by

Founders

Cosigned by

Featured roles

Team

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Data current as of July 20, 2026

Organization name

A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.

Backed byDetails being loaded

Cosigned byDetails being loaded

Team on CosignDetails being loaded

Team

Profile nameProfile nameProfile name

Team

Profile nameProfile nameProfile name

Cosigns Received

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Cosigner name

A thoughtful collaborator who builds great products and supports the people around them.

Profile name

Freenome

Freenome combines AI-powered multiomics with simple blood draws to detect cancer earlier; its SimpleScreen CRC test earned FDA approval in 2026.

Backed by

Founders

Cosigned by

Featured roles

Team

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Data current as of July 20, 2026

Profile name

Company name

Company name

Profile name

Company name

Company name

Organization name

Team

Team

Team

Cosigns Received

Profile name

Company name

Company name

Freenome

Team

Team

Team

Funding

Organization name

Team

Team

Team

Cosigns Received

Freenome

Team

Team

Team

Funding